New Targets, Diseases for CAR T-Cell Therapy – MedPage Today
MedPage Today |
New Targets, Diseases for CAR T-Cell Therapy
MedPage Today In quick succession this summer and fall, the FDA granted the first two approvals of CAR T-cell therapy for malignant diseases: tisagenlecleucel (Kymriah) in late August for children and young adults with relapsed/refractory acute lymphoblastic … |
